MedPath

The effect of Wenjing Huayu Zhitong treatment on endocrine-immune mechanism of rats with primary dysmenorrhea and the effect of immediate clinical analgesic in patients

Phase 1
Completed
Conditions
Primary Dysmenorrhea
Registration Number
ITMCTR1900002530
Lead Sponsor
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Western diagnostic criteria for primary dysmenorrhea;
(2) TCM syndrome differentiation standards consistent with cold coagulation syndrome;
(3) Aged 18 to 35 years old, regular menstruation, and the period is 21 to 35 days;
(4) The drug for treating dysmenorrhea has not been taken for nearly two months.

Exclusion Criteria

1. Planned pregnant or lactating women;
2. Western medicine diagnosis of secondary dysmenorrhea, examination of dysmenorrhea caused by pelvic organic diseases such as endometriosis, uterine fibroids, adenomyosis;
3. Patients with serious systemic diseases such as cardiovascular, liver, kidney and hematopoietic system, and mental patients;
4. Allergic constitution, allergic to two or more drugs, foods, or allergic to the known ingredients of this study;
5. Those who are participating in other clinical drug trials or are using drugs that have similar therapeutic effects as the study drug.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual analogue scale;Pain accumulation time;
Secondary Outcome Measures
NameTimeMethod
CD4+;CD8+;TCM symptom score;PGF2 alpha;CD3+;
© Copyright 2025. All Rights Reserved by MedPath